Published in Biochem Biophys Res Commun on May 31, 1990
Glycosaminoglycans and the regulation of blood coagulation. Biochem J (1993) 1.57
Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest (1993) 1.45
Recombinant human thrombomodulin. Regulation of cofactor activity and anticoagulant function by a glycosaminoglycan side chain. Biochem J (1992) 0.83
Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol (1985) (2001) 5.63
Evans blue dye as a marker of albumin clearance in cultured endothelial monolayer and isolated lung. J Appl Physiol (1985) (1992) 2.50
Thrombin-induced increase in albumin permeability across the endothelium. J Cell Physiol (1986) 2.04
Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol (2001) 1.80
Mechanisms regulating endothelial cell barrier function. Am J Physiol Lung Cell Mol Physiol (2000) 1.77
Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest (1987) 1.74
Differential regulation of alternatively spliced endothelial cell myosin light chain kinase isoforms by p60(Src). J Biol Chem (2000) 1.56
Microtubule disassembly increases endothelial cell barrier dysfunction: role of MLC phosphorylation. Am J Physiol Lung Cell Mol Physiol (2001) 1.52
Involvement of c-Src in diperoxovanadate-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol (2000) 1.51
Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis. J Hematother Stem Cell Res (1999) 1.43
A single human myosin light chain kinase gene (MLCK; MYLK). Genomics (1999) 1.37
Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII. Am Rev Respir Dis (1987) 1.31
Measurement of albumin permeability across endothelial monolayers in vitro. J Appl Physiol (1985) (1987) 1.30
Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells. J Biol Chem (1990) 1.30
Effects of moxalactam on blood coagulation and platelet function. Rev Infect Dis (1983) 1.24
Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc Res (2001) 1.23
Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol (2001) 1.21
Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity. Am J Respir Cell Mol Biol (2001) 1.19
Activation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid hydroperoxide. J Biol Chem (1993) 1.17
Assessment of interlobar variation of bronchoalveolar lavage cellular differentials in interstitial lung diseases. Am Rev Respir Dis (1986) 1.15
Expression of a novel myosin light chain kinase in embryonic tissues and cultured cells. J Biol Chem (1995) 1.13
Role of ras-dependent ERK activation in phorbol ester-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol (2000) 1.10
Expression of a novel high molecular-weight myosin light chain kinase in endothelium. Am J Respir Cell Mol Biol (1998) 1.09
Rationale for juxtacrine regulation of neutrophil interactions with the stimulated endothelium. J Lab Clin Med (1995) 1.09
Recombinant human protein C derivatives: altered response to calcium resulting in enhanced activation by thrombin. EMBO J (1990) 1.09
Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. Am J Physiol (1995) 1.08
Biochemical regulation of the nonmuscle myosin light chain kinase isoform in bovine endothelium. Am J Respir Cell Mol Biol (1998) 1.07
Role of cAMP-dependent protein kinase A activity in endothelial cell cytoskeleton rearrangement. Am J Physiol Lung Cell Mol Physiol (2001) 1.05
Ampicillin, tetracycline, and chloramphenicol resistant Haemophilus influenzae in adults with chronic lung disease. Relationship of resistance to prior antimicrobial therapy. Am Rev Respir Dis (1988) 1.04
Serine protease specificity for peptide chromogenic substrates. Thromb Haemost (1977) 1.04
Effects of benoxaprofen and indomethacin on platelet function and biochemistry. J Rheumatol Suppl (1980) 1.03
Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase in vascular endothelial cells. Am J Physiol (1999) 1.01
Activation of endothelial cell phospholipase D by sphingosine and sphingosine-1-phosphate. Am J Respir Cell Mol Biol (1994) 1.00
Regulation of endothelial cell barrier function by calcium/calmodulin-dependent protein kinase II. Am J Physiol Lung Cell Mol Physiol (2001) 1.00
Regulation of endothelial barrier function by the cAMP-dependent protein kinase. Endothelium (2000) 0.99
NHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases. Am J Physiol Cell Physiol (2001) 0.98
The usefulness of bronchoalveolar lavage in identifying past occupational exposure to asbestos: a light and electron microscopy study. Am J Ind Med (1991) 0.98
High-efficiency transient transfection of endothelial cells for functional analysis. FASEB J (2000) 0.97
Thrombin-mediated focal adhesion plaque reorganization in endothelium: role of protein phosphorylation. Am J Respir Cell Mol Biol (1997) 0.97
Bronchoalveolar lavage fluid evaluation in rheumatoid arthritis. Am Rev Respir Dis (1986) 0.96
Protein kinase C phosphorylates caldesmon77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers. J Cell Physiol (1992) 0.96
Plasma protein requirements for human platelet aggregation. Ann N Y Acad Sci (1972) 0.95
Low-dose fibrinolytic therapy. Results and new concepts. Radiology (1983) 0.95
Mechanisms of pertussis toxin-induced barrier dysfunction in bovine pulmonary artery endothelial cell monolayers. Am J Physiol (1995) 0.94
Leeches, snakes, ticks, and vampire bats in today's cardiovascular drug development. Circulation (1991) 0.93
Expression of inducible nitric oxide synthase (iNOS) mRNA in inflamed esophageal and colonic mucosa in a pediatric population. Am J Gastroenterol (1998) 0.93
Gamma-carboxylated isoforms of recombinant human protein S with different biologic properties. Blood (1990) 0.92
Hyperoxic exposure in humans. Effects of 50 percent oxygen on alveolar macrophage leukotriene B4 synthesis. Chest (1992) 0.92
Mechanisms of sodium fluoride-induced endothelial cell barrier dysfunction: role of MLC phosphorylation. Am J Physiol Lung Cell Mol Physiol (2001) 0.91
Hydroperoxide-induced diacylglycerol formation and protein kinase C activation in vascular endothelial cells. Arch Biochem Biophys (1993) 0.90
Phosphorylation by casein kinase II alters the biological activity of calmodulin. Biochem J (1992) 0.89
Introduction of C3 exoenzyme into cultured endothelium by lipofectamine. Anal Biochem (2000) 0.89
Differences in Ca2+ mobilization by muscarinic agonists in tracheal smooth muscle. Am J Physiol (1993) 0.89
Leukotrienes and the pulmonary microcirculation. Am Rev Respir Dis (1987) 0.88
Chemotactic migration triggers IL-8 generation in neutrophilic leukocytes. J Immunol (1999) 0.88
Role of tyrosine phosphorylation in thrombin-induced endothelial cell contraction and barrier function. Endothelium (1998) 0.87
Platelet-activating factor increases lung vascular permeability to protein. J Appl Physiol (1985) (1986) 0.86
Effects of a vitamin K-deficient diet and antibiotics in normal human volunteers. J Lab Clin Med (1987) 0.86
Regulation of endothelial cell myosin light chain phosphorylation and permeability by vanadate. J Cell Biochem (1998) 0.86
Neutrophil collagenase in rheumatoid interstitial lung disease. J Appl Physiol (1985) (1987) 0.86
Induction of endothelial monolayer permeability by phosphatidate. J Cell Biochem (1999) 0.85
Functional properties of carbohydrate-depleted tissue plasminogen activator. Biochemistry (1984) 0.85
Analysis of the plasminogen activator activity of the human glomerulus. Kidney Int (1988) 0.85
Reproductive health risk behavior survey of Colombian high school students. J Adolesc Health (1999) 0.85
Exogenous fatty acids modulate the functional and cytotoxic responses of cultured pulmonary artery endothelial cells to oxidant stress. J Lab Clin Med (1997) 0.85
Mechanisms of cholera toxin prevention of thrombin- and PMA-induced endothelial cell barrier dysfunction. Microvasc Res (1994) 0.84
Agonist-induced activation of phospholipase D in bovine pulmonary artery endothelial cells: regulation by protein kinase C and calcium. J Lab Clin Med (1993) 0.84
Abnormal platelet function in Chediak-Higashi syndrome. Br J Haematol (1977) 0.84
Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome. N Engl J Med (1992) 0.84
Hemostasis and fibrinolysis in renal transplantation. Semin Thromb Hemost (1989) 0.84
Role of Src kinase in diperoxovanadate-mediated activation of phospholipase D in endothelial cells. Arch Biochem Biophys (2001) 0.83
Phosphatidic acid directly activates endothelial cell protein kinase C. Biochem Biophys Res Commun (1993) 0.83
Recombinant human thrombomodulin. Regulation of cofactor activity and anticoagulant function by a glycosaminoglycan side chain. Biochem J (1992) 0.83
Role of Ca2+/calmodulin-dependent phosphatase 2B in thrombin-induced endothelial cell contractile responses. Am J Physiol (1998) 0.83
Relationship between post-translational glycosylation and anticoagulant function of secretable recombinant mutants of human thrombomodulin. Br J Haematol (1991) 0.83
Fluoride mobilizes intracellular calcium and promotes Ca2+ influx in rat proximal tubules. Am J Physiol (1991) 0.83
Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III. Eur J Biochem (1991) 0.82
Vitamin K-dependent carboxylase: possible role of the substrate "propeptide" as an intracellular recognition site. Proc Natl Acad Sci U S A (1987) 0.82
Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli. J Biol Chem (1990) 0.82
Role of p38 MAP kinase in diperoxovanadate-induced phospholipase D activation in endothelial cells. Am J Physiol Lung Cell Mol Physiol (2001) 0.81
Deleterious effects of calcium deprivation on freshly isolated hepatocytes. Am J Physiol (1981) 0.81
High-performance liquid chromatographic analysis of radiolabeled inositol phosphates. Anal Biochem (1990) 0.81
Enhancement of blood coagulation by soluble fibrin complexes. J Exp Med (1975) 0.81
Formation of soluble fibrin polymers. Fibrinogen degradation fragments D and E fail to form soluble complexes with fibrin monomer. Biochemistry (1972) 0.81
Enhanced platelet function in glomerular renal disease. J Lab Clin Med (1973) 0.81
Peritoneal fibrinolysis: evidence for the efficiency of the tissue-type plasminogen activator. J Lab Clin Med (1983) 0.81
Plasminogen activator in mouse uterine fluid: its suppression by estradiol and progesterone. Proc Soc Exp Biol Med (1966) 0.81
The influence of plasma proteins on human platelet metabolism. Thromb Res (1979) 0.81
The role of protein kinase C in alpha-thrombin-mediated endothelial cell activation. Semin Thromb Hemost (1992) 0.81
Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens. Arterioscler Thromb (1992) 0.80
Immunochemical characterization of myosin-specific phosphatase 1 regulatory subunits in bovine endothelium. J Cell Biochem (2000) 0.80
Phosphorylation of calmodulin in the first calcium-binding pocket by myosin light chain kinase. Arch Biochem Biophys (1996) 0.80
Analysis of ferruginous bodies in bronchoalveolar lavage from foundry workers. Br J Ind Med (1993) 0.80
Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states. Ser Haematol (1973) 0.79
Sensitivity and specificity of plasma serine protease chromogenic substrates. Haemostasis (1978) 0.79
Direct expression of recombinant activated human protein C, a serine protease. J Biol Chem (1989) 0.79
Combined heterozygosity of factor V leiden and the G20210A prothrombin gene mutation in a patient with cerebral cortical vein thrombosis. Am J Hematol (2000) 0.78
[Reorganization of microtubule system in pulmonary endothelial cells in response to thrombin treatment]. Tsitologiia (2004) 0.78